OO
LIVE

Serial Number

97409086

Owner

Crown Bioscience Inc.

Attorney

Yi Zhang

Filing Date

May 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

OO Trademark

Serial Number: 97409086

OO is a trademark filed by Crown Bioscience Inc. on May 13, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 31 (Natural Agricultural Products). The application is currently pending registration.

Owner Contact Info

Crown Bioscience Inc. (29 trademarks)

Santa Clara, CA 95054

Entity Type: 03

Trademark Details

Filing Date

May 13, 2022

Registration Date

Not Registered

Published for Opposition

May 27, 2025

Goods & Services

Downloadable computer application software for mobile phones, namely, software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable computer software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable mobile applications for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell; line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable software in the nature of a mobile application for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data

Live animals; Live animals, namely, rodent animal, specifically, rats; Live laboratory animals

Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development services; Providing a members-only website featuring technology which provides members with the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a secured-access, members only website featuring technology that gives members the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a web site featuring technology that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring on-line nondownloadable software that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring resources, namely, non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatment; Scientific laboratory services; Scientific research for medical purposes in the area of cancerous diseases; Technical research in the field of pharmaceutical studies

Drug use screening services; Drug use testing services; Drug, alcohol and DNA screening for medical purposes; Medical screening; Medical services, namely, preemployment drug screening; Providing information in the field of cancer prevention, screening, diagnosis and treatment

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 22, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jan 22, 2026 EX1G
SOU EXTENSION 1 FILED
Jan 21, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 21, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 22, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 21, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2025 CRFA
REINSTATEMENT GRANTED - RESPONSE RECEIVED
Mar 19, 2025 RGRR
PETITION TO DIRECTOR GRANTED
Mar 19, 2025 PCGR
ASSIGNED TO PETITION STAFF
Mar 11, 2025 APET
TEAS PETITION TO DIRECTOR RECEIVED
Nov 24, 2024 TPDR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 25, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 25, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 25, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 25, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 11, 2024 GNFN
FINAL REFUSAL E-MAILED
Jun 11, 2024 GNFR
FINAL REFUSAL WRITTEN
Jun 11, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2023 CRFA
ASSIGNED TO LIE
Nov 8, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 6, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 19, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2022 NWOS
NEW APPLICATION ENTERED
May 17, 2022 NWAP